Lakefront Biotherapeutics N.V. ( LKFT) - Stock Earnings
LKFT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
LKFT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -202.1 million USD | 71.2 million USD |
| 2025Q4 | 782.1 million USD | 900.8 million USD |
| 2026Q1 | 14.5 million USD | 6.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
LKFT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 211.7 million EUR | 239.7 million EUR |
| 2024 | 74.1 million USD | 275.6 million USD |
| 2025 | 320.9 million USD | 1.1 billion USD |
| 2026 Est. | — | — |
LKFT
Price: $31.40
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.9 billion